La National Eating Disorders Collaboration (NEDC) ha integrado dos décadas de consenso del sector y experiencia vivida y desarrollo de servicios en un modelo del sistema escalonado de atención para los trastornos alimentarios (Figura 1).
Read more
Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
Current clinical guidelines for the treatment of eating disorders in Australia are aimed at treatments for medical and psychiatric care in line with the DSM-5 and International Classification of Diseases (ICD-10).
Read more
